X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1268) 1268
Publication (80) 80
Patent (18) 18
Book Review (16) 16
Book Chapter (4) 4
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (686) 686
index medicus (407) 407
pharmacology & pharmacy (399) 399
female (356) 356
male (321) 321
oncology (305) 305
pharmacokinetics (274) 274
middle aged (231) 231
animals (223) 223
adult (213) 213
aged (177) 177
chemistry, analytical (164) 164
cancer (163) 163
mice (159) 159
antineoplastic agents - pharmacokinetics (127) 127
biochemical research methods (118) 118
neoplasms - drug therapy (117) 117
pharmacology/toxicology (117) 117
reproducibility of results (109) 109
analysis (104) 104
mass spectrometry (104) 104
medicine & public health (101) 101
administration, oral (90) 90
area under curve (83) 83
research (82) 82
phase-i (79) 79
plasma (79) 79
chemotherapy (77) 77
metabolites (76) 76
antineoplastic agents (75) 75
sensitivity and specificity (75) 75
dose-response relationship, drug (71) 71
p-glycoprotein (71) 71
care and treatment (70) 70
antimitotic agents (68) 68
metabolism (66) 66
chromatography, high pressure liquid (65) 65
mice, knockout (64) 64
pharmacology (64) 64
biological availability (62) 62
liquid chromatography (61) 61
paclitaxel (61) 61
antineoplastic agents - administration & dosage (60) 60
drug stability (60) 60
chromatography, high pressure liquid - methods (58) 58
drug interactions (58) 58
chromatography, liquid - methods (56) 56
tandem mass spectrometry - methods (55) 55
toxicity (55) 55
internal medicine (54) 54
pharmacy (53) 53
tissue distribution (53) 53
time factors (51) 51
antineoplastic agents - therapeutic use (50) 50
hiv infections - drug therapy (50) 50
treatment outcome (50) 50
cell lung-cancer (49) 49
lc-ms/ms (49) 49
breast cancer (48) 48
drug administration schedule (48) 48
models, biological (48) 48
paclitaxel - pharmacokinetics (48) 48
antineoplastic agents, phytogenic - pharmacokinetics (47) 47
infectious diseases (47) 47
drugs (46) 46
pharmacodynamics (46) 46
pharmacotherapy (46) 46
bioavailability (45) 45
drug therapy (45) 45
therapy (45) 45
breast-cancer (44) 44
dosage and administration (44) 44
toxicology (44) 44
antineoplastic agents - adverse effects (42) 42
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
population pharmacokinetics (42) 42
aged, 80 and over (41) 41
antineoplastic agents - blood (41) 41
tumors (41) 41
validation (41) 41
infusions, intravenous (40) 40
neoplasms - metabolism (40) 40
antineoplastic agents - pharmacology (39) 39
performance liquid-chromatography (39) 39
biochemistry & molecular biology (38) 38
breast neoplasms - drug therapy (38) 38
dogs (38) 38
adolescent (37) 37
in-vitro (37) 37
deoxycytidine - analogs & derivatives (36) 36
drug therapy, combination (36) 36
human plasma (36) 36
solid tumors (36) 36
calibration (35) 35
paclitaxel - administration & dosage (35) 35
carboplatin (34) 34
docetaxel (34) 34
risk factors (34) 34
atp-binding cassette transporters - metabolism (33) 33
biomedicine (33) 33
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ChemMedChem, ISSN 1860-7179, 05/2013, Volume 8, Issue 5, p. 858
Journal Article
Xenobiotica, ISSN 0049-8254, 12/2016, Volume 46, Issue 12, pp. 1122 - 1132
Omacetaxine mepesuccinate (hereafter referred to as omacetaxine) is a protein translation inhibitor approved by the US Food and Drug Administration for adult... 
Disposition | pharmacokinetics | homoharringtonine | metabolism | mepesuccinate | metabolites | metabolite profiling | omacetaxine
Journal Article
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 06/2019, p. 107815521985029
Journal Article
Clinical breast cancer, ISSN 1526-8209, 08/2015, Volume 15, Issue 4, p. 241
Tamoxifen, an endocrine agent, is widely used in the treatment of estrogen receptor-positive breast cancer. It has greatly reduced disease recurrence and... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1639 - 1650
Journal Article
Pharmaceutisch Weekblad, ISSN 0031-6911, 02/2018, Volume 153, Issue 7, pp. 22 - 23
Journal Article
British Medical Journal, ISSN 0959-8146, 11/2012, Volume 345, Issue 7884, p. 27
  Dorlo et al support the proposed new definitions for the quality of medicines and the plead for a global treaty tackling both substandard production and... 
Drugs | Product quality | Treaties | Patients | Tropical diseases
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 11/2012, Volume 67, Issue 11, pp. 2576 - 2597
Journal Article
Investigational new drugs, ISSN 0167-6997, 2015, Volume 33, Issue 1, pp. 201 - 214
Background This phase I/II study determined the maximal tolerable dose, dose limiting toxicities, antitumor activity, the pharmacokinetics and pharmacodynamics... 
NAMI-A | Ruthenium | Phase I | Medicine & Public Health | Gemcitabine | Non-small cell lung cancer | Oncology | Phase II | Pharmacology/Toxicology | Clinical study | TRANS-IMIDAZOLEDIMETHYLSULFOXIDE-TETRACHLORORUTHENATE | DNA-BINDING | METASTASIS | CHEMICAL-STABILITY | TUMORS | PLATINUM COMPLEXES | INHIBITION | LIQUID-CHROMATOGRAPHY | ONCOLOGY | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | CYTOTOXICITY | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ruthenium - administration & dosage | Deoxycytidine - pharmacokinetics | Ruthenium - adverse effects | Adult | Deoxycytidine - adverse effects | Dimethyl Sulfoxide - administration & dosage | Female | Ruthenium - blood | Dimethyl Sulfoxide - adverse effects | Organometallic Compounds - adverse effects | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - metabolism | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Ruthenium - pharmacokinetics | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Dimethyl Sulfoxide - analogs & derivatives | Deoxycytidine - analogs & derivatives | Dimethyl Sulfoxide - pharmacokinetics | Organometallic Compounds - administration & dosage | Complications and side effects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Studies | Clinical trials | Lung cancer | Pharmaceutical sciences | Clinical outcomes | Index Medicus
Journal Article
Oncologist, ISSN 1083-7159, 07/2011, Volume 16, Issue 7, pp. 1006 - 1020
Journal Article